JENNIFER RICE: Open Payments
NPI 1841225083 · ESTERO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$318 in 15 payments from 10 companies in 2025. Trend: 2023 $1,015 · 2024 $465 · 2025 $318
Food & beverage: $318
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $126 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Amgen Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Janssen Biotech, Inc. | 1 | $19 |
| Galderma Laboratories, L.P. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Incyte Corporation | 1 | $16 |
Products named: DUPIXENT, OTEZLA, SKYRIZI, Rhapsido, TREMFYA, NEMLUVIO, CIBINQO, Zoryve.
Industry payments across FL — which companies pay providers there.
